Identification of blood plasma protein ratios for distinguishing Alzheimer's disease from healthy controls using machine learning
Early detection of Alzheimer's disease is essential for effective treatment and the development of therapies that modify disease progression. Developing sensitive and specific noninvasive diagnostic tools is crucial for improving clinical outcomes and advancing our understanding of this conditi...
Saved in:
Main Authors: | Ali Safi, Elisa Giunti, Omar Melikechi, Weiming Xia, Noureddine Melikechi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025007297 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
by: Yo-Ting Tsai, et al.
Published: (2024-03-01) -
Identification of Plasma Proteins Associated with Alzheimer's Disease Using Feature Selection Techniques and Machine Learning Algorithms
by: Zakaria Mokadem, et al.
Published: (2025-02-01) -
Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort
by: Neetesh Pandey, et al.
Published: (2025-01-01) -
Proteomics unveil candidate biomarkers and pathogenesis of subacute thyroiditis
by: Litong Ran, et al.
Published: (2025-02-01) -
Investigating the Therapeutic Mechanisms of Total Saikosaponins in Alzheimer’s Disease: A Metabolomic and Proteomic Approach
by: Huiling Wei, et al.
Published: (2025-01-01)